SGOT Levels in Acute Myocardial Infarction Patients with Mayor Adverse Cardiovascular Events (MACE)
- DOI
- 10.2991/978-94-6463-048-0_34How to use a DOI?
- Keywords
- acute myocardial infarction; major adverse cardiovascular events; SGOT
- Abstract
SGOT is one of the most widely available biomarkers of myocardial infarction in various health care facilities in Indonesia. In the clinical course of acute myocardial infarction, major adverse cardiovascular events (MACE) may occur which include death, CHF, stroke, arrhythmia, and cardiogenic shock. To know the profile of SGOT levels in AMI patients with MACE and to determine the relationship between SGOT levels and the amount of MACE.This was a retrospective cohort study. The data was taken from the medical records of patients at RSUD Dr Sudirman, Kebumen. The inclusion criteria were AMI patients with MACE and the exclusion criteria were patients with liver disease and incomplete medical records. We used descriptive analysis to present the data and correlation between SGOT levels and the amount of MACE was carried out by Spearman's test.There were 50 samples included in this study. AMI was more common in patients aged > 50 years (92%) and mostly in men (60%). The proportion of subjects with MACE in this study were 39%, 3.125%, 34.375%, and 23% for CHF, stroke, arrhythmia and cardiogenic shock respectively. The median of SGOT levels in each MACE group were CHF 54 (26–975) U/L, Stroke 74.5 (32–117) U/L, arrhythmia 58 (23–975) U/L, cardiogenic shock 45 (23–251) U/L. There was no relationship between increased levels of SGOT and the number of MACE events (p 0.434).Highest median of SGOT levels was found in the stroke group. There was no relationship between increased levels of SGOT with the number of major adverse cardiovascular events (MACE) in patients with acute myocardial infarction.
- Copyright
- © 2023 The Author(s)
- Open Access
- Open Access This chapter is licensed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.
Cite this article
TY - CONF AU - Iis Siti Aisah AU - Rahma Yuantari AU - Linda Rosita PY - 2022 DA - 2022/12/19 TI - SGOT Levels in Acute Myocardial Infarction Patients with Mayor Adverse Cardiovascular Events (MACE) BT - Proceedings of the 3rd International Conference on Cardiovascular Diseases (ICCvD 2021) PB - Atlantis Press SP - 301 EP - 307 SN - 2468-5739 UR - https://doi.org/10.2991/978-94-6463-048-0_34 DO - 10.2991/978-94-6463-048-0_34 ID - Aisah2022 ER -